Bauss F - Search Results

1

Changes in bone structure after augmentation cystoplasty in chronic uraemic rats.

Brkovic D, Linke J, Jakse G, Bauss F. Brkovic D, et al. Among authors: bauss f. BJU Int. 2005 May;95(7):1066-70. doi: 10.1111/j.1464-410X.2005.05468.x. BJU Int. 2005. PMID: 15839934

2

Effect of augmentation cystoplasty on bone metabolism in chronic uremic rats.

Brkovic D, Seibel M, Juchem R, Linke J, Rohde D, Bauss F. Brkovic D, et al. Among authors: bauss f. J Urol. 2004 Feb;171(2 Pt 1):921-5. doi: 10.1097/01.ju.0000104561.90514.cb. J Urol. 2004. PMID: 14713854

3

Impaired bone metabolism following augmentation cystoplasties in growing rats.

Brkovic D, Seibel M, Kissling C, Dörsam J, Wiesel M, Staehler G, Bauss F. Brkovic D, et al. Among authors: bauss f. Eur Urol. 2000 Dec;38(6):766-73. doi: 10.1159/000020377. Eur Urol. 2000. PMID: 11111199

4

Site-specific human breast cancer (MDA-MB-231) metastases in nude rats: model characterisation and in vivo effects of ibandronate on tumour growth.

Neudert M, Fischer C, Krempien B, Bauss F, Seibel MJ. Neudert M, et al. Among authors: bauss f. Int J Cancer. 2003 Nov 10;107(3):468-77. doi: 10.1002/ijc.11397. Int J Cancer. 2003. PMID: 14506749

5

Total administered dose of ibandronate determines its effects on bone mass and architecture in ovariectomized aged rats.

Bauss F, Wagner M, Hothorn LH. Bauss F, et al. J Rheumatol. 2002 May;29(5):990-8. J Rheumatol. 2002. PMID: 12022363

6

Preventative ibandronate treatment has the most beneficial effect on the microstructure of bone in experimental tumor osteolysis.

Kurth AA, Kim SZ, Shea M, Bauss F, Hayes WC, Müller R. Kurth AA, et al. Among authors: bauss f. J Bone Miner Metab. 2007;25(2):86-92. doi: 10.1007/s00774-006-0732-x. Epub 2007 Feb 26. J Bone Miner Metab. 2007. PMID: 17323177 Free article.

7

Association between histomorphometry and biochemical markers of bone turnover in a longitudinal rat model of parathyroid hormone-related peptide (PTHrP)-mediated tumor osteolysis.

Juraschek M, Seibel MJ, Woitge HW, Krempien B, Bauss F. Juraschek M, et al. Among authors: bauss f. Bone. 2000 May;26(5):475-83. doi: 10.1016/S8756-3282(00)00259-3. Bone. 2000. PMID: 10773587

8

Lifelong administration of high doses of ibandronate increases bone mass and maintains bone quality of lumbar vertebrae in rats.

Lalla S, Hothorn LA, Haag N, Bader R, Bauss F. Lalla S, et al. Among authors: bauss f. Osteoporos Int. 1998;8(2):97-103. doi: 10.1007/BF02672503. Osteoporos Int. 1998. PMID: 9666930

9

Effects of treatment with ibandronate on bone mass, architecture, biomechanical properties, and bone concentration of ibandronate in ovariectomized aged rats.

Bauss F, Lalla S, Endele R, Hothorn LA. Bauss F, et al. J Rheumatol. 2002 Oct;29(10):2200-8. J Rheumatol. 2002. PMID: 12375334

10

The bisphosphonate ibandronate accelerates osseointegration of hydroxyapatite-coated cementless implants in an animal model.

Eberhardt C, Habermann B, Müller S, Schwarz M, Bauss F, Kurth AH. Eberhardt C, et al. Among authors: bauss f. J Orthop Sci. 2007 Jan;12(1):61-6. doi: 10.1007/s00776-006-1081-2. Epub 2007 Jan 31. J Orthop Sci. 2007. PMID: 17260119

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

63 results

Search Page

Filters